Cargando…

Identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms

The prediction of the liver failure (LF) and its proper diagnosis would lead to a reduction in the complications of the disease and prevents the progress of the disease. To improve the treatment of LF patients and reduce the cost of treatment, we build a machine learning model to forecast whether a...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Junfeng, Zhou, Mi, Chen, Chuan, Xie, Xiaohua, Luo, Ching-Hsing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546449/
https://www.ncbi.nlm.nih.gov/pubmed/33035213
http://dx.doi.org/10.1371/journal.pone.0239266
_version_ 1783592229883871232
author Peng, Junfeng
Zhou, Mi
Chen, Chuan
Xie, Xiaohua
Luo, Ching-Hsing
author_facet Peng, Junfeng
Zhou, Mi
Chen, Chuan
Xie, Xiaohua
Luo, Ching-Hsing
author_sort Peng, Junfeng
collection PubMed
description The prediction of the liver failure (LF) and its proper diagnosis would lead to a reduction in the complications of the disease and prevents the progress of the disease. To improve the treatment of LF patients and reduce the cost of treatment, we build a machine learning model to forecast whether a patient would deteriorate after admission to the hospital. First, a total of 348 LF patients were included from May 2011 to March 2018 retrospectively in this study. Then, 15 key clinical indicators are selected as the input of the machine learning algorithm. Finally, machine learning and the Model for End-Stage Liver Disease (MELD) are used to forecast the LF deterioration. The area under the receiver operating characteristic (AUC) of MELD, GLMs, CART, SVM and NNET with 10 fold-cross validation was 0.670, 0.554, 0.794, 0.853 and 0.912 respectively. Additionally, the accuracy of MELD, GLMs, CART, SVM and NNET was 0.669, 0.456, 0.794, 0.853 and 0.912. The predictive performance of the developed machine model execept the GLMs exceeds the classic MELD model. The machine learning method could support the physicians to trigger the initiation of timely treatment for the LD patients.
format Online
Article
Text
id pubmed-7546449
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-75464492020-10-19 Identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms Peng, Junfeng Zhou, Mi Chen, Chuan Xie, Xiaohua Luo, Ching-Hsing PLoS One Research Article The prediction of the liver failure (LF) and its proper diagnosis would lead to a reduction in the complications of the disease and prevents the progress of the disease. To improve the treatment of LF patients and reduce the cost of treatment, we build a machine learning model to forecast whether a patient would deteriorate after admission to the hospital. First, a total of 348 LF patients were included from May 2011 to March 2018 retrospectively in this study. Then, 15 key clinical indicators are selected as the input of the machine learning algorithm. Finally, machine learning and the Model for End-Stage Liver Disease (MELD) are used to forecast the LF deterioration. The area under the receiver operating characteristic (AUC) of MELD, GLMs, CART, SVM and NNET with 10 fold-cross validation was 0.670, 0.554, 0.794, 0.853 and 0.912 respectively. Additionally, the accuracy of MELD, GLMs, CART, SVM and NNET was 0.669, 0.456, 0.794, 0.853 and 0.912. The predictive performance of the developed machine model execept the GLMs exceeds the classic MELD model. The machine learning method could support the physicians to trigger the initiation of timely treatment for the LD patients. Public Library of Science 2020-10-09 /pmc/articles/PMC7546449/ /pubmed/33035213 http://dx.doi.org/10.1371/journal.pone.0239266 Text en © 2020 Peng et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Peng, Junfeng
Zhou, Mi
Chen, Chuan
Xie, Xiaohua
Luo, Ching-Hsing
Identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms
title Identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms
title_full Identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms
title_fullStr Identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms
title_full_unstemmed Identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms
title_short Identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms
title_sort identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546449/
https://www.ncbi.nlm.nih.gov/pubmed/33035213
http://dx.doi.org/10.1371/journal.pone.0239266
work_keys_str_mv AT pengjunfeng identificationofexacerbationriskinpatientswithliverdysfunctionusingmachinelearningalgorithms
AT zhoumi identificationofexacerbationriskinpatientswithliverdysfunctionusingmachinelearningalgorithms
AT chenchuan identificationofexacerbationriskinpatientswithliverdysfunctionusingmachinelearningalgorithms
AT xiexiaohua identificationofexacerbationriskinpatientswithliverdysfunctionusingmachinelearningalgorithms
AT luochinghsing identificationofexacerbationriskinpatientswithliverdysfunctionusingmachinelearningalgorithms